4//SEC Filing
San Martin Javier 4
Accession 0001628280-23-039850
CIK 0000879407other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 2:31 PM ET
Size
7.5 KB
Accession
0001628280-23-039850
Insider Transaction Report
Form 4
San Martin Javier
Chief Medical Officer
Transactions
- Sale
Common Stock
2023-11-20$28.73/sh−14,758$423,997→ 136,742 total - Sale
Common Stock
2023-11-20$29.00/sh−4,942$143,318→ 131,800 total
Footnotes (3)
- [F1]The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $27.97 to $28.90, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
- [F2]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.
- [F3]The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $28.91 to $29.15, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
Documents
Issuer
ARROWHEAD PHARMACEUTICALS, INC.
CIK 0000879407
Entity typeother
Related Parties
1- filerCIK 0001794629
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 2:31 PM ET
- Size
- 7.5 KB